FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nevro's Free Cash Flow for the
three
months ended in Dec. 2023 was $-10.8 Mil. Nevro's Revenue for the
three
months ended in Dec. 2023 was $116.2 Mil. Therefore, Nevro's FCF Margin % for the quarter that ended in Dec. 2023 was -9.28%.
The historical rank and industry rank for Nevro's FCF Margin % or its related term are showing as below:
NVRO'
s FCF Margin % Range Over the Past 10 Years
Min: -151.48 Med: -13.89 Max: 4.22
Current: -15.86
During the past 12 years, the highest FCF Margin % of Nevro was 4.22%. The lowest was -151.48%. And the median was -13.89%.
NVRO's FCF Margin % is ranked worse than 57.7% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: -7.12
vs NVRO: -15.86
Nevro FCF Margin % Historical Data
The historical data trend for Nevro's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nevro's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nevro's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nevro's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nevro's FCF Margin % falls into.
Nevro FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Nevro's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nevro FCF Margin % Related Terms
Thank you for viewing the detailed overview of Nevro's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVRO has been successfully added to your 